Evaluating the safety and efficacy of recombinant human thrombopoietin among severe sepsis patients with thrombocytopenia: study protocol for a randomized controlled trial
2015 · Trials · 7 citations
https://doi.org/10.1186/s13063-015-0746-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
7
Citations
1
h-index
0
i10-index
Gunawei Li is an academic researcher from Nanjing General Hospital of Nanjing Military Command. The author has contributed to research in topics: Sepsis Diagnosis and Treatment & Platelet Disorders and Treatments & Blood properties and coagulation. The author has an h-index of 1, co-authored 1 publications.
Click to start Chat